Elawyers Elawyers
Ohio| Change

IN RE AVALANCHE BIOTECHNOLOGIES SECURITIES LITIGATION, 15-cv-03185-JD. (2015)

Court: District Court, N.D. California Number: infdco20151218b01 Visitors: 8
Filed: Dec. 17, 2015
Latest Update: Dec. 17, 2015
Summary: ORDER RE LEAD PLAINTIFF AND COUNSEL; AMENDED SCHEDULING ORDER Re: Dkt. Nos. 13, 17, 21, 26, 27 JAMES DONATO , District Judge . The Court issues these orders in this consolidated securities class action. The orders apply in the three cases (15-cv-3185, 15-cv-3231, 15-cv-3281) that have been consolidated for pretrial purposes under this master docket. Dkt. No. 48 1-2. I. APPOINTMENT OF LEAD PLAINTIFF AND LEAD COUNSEL Putative class members filed five competing motions seeking appointment
More

ORDER RE LEAD PLAINTIFF AND COUNSEL; AMENDED SCHEDULING ORDER Re: Dkt. Nos. 13, 17, 21, 26, 27

The Court issues these orders in this consolidated securities class action. The orders apply in the three cases (15-cv-3185, 15-cv-3231, 15-cv-3281) that have been consolidated for pretrial purposes under this master docket. Dkt. No. 48 ¶¶ 1-2.

I. APPOINTMENT OF LEAD PLAINTIFF AND LEAD COUNSEL

Putative class members filed five competing motions seeking appointment as lead plaintiff under the Private Securities Litigation Reform Act ("PSLRA"), 15 U.S.C. § 78u-4(a)(3)(B)(i). Dkt. Nos. 13, 17, 21, 26, and 27. Two parties — Srikanth Dropati and the Beaver County Employees Retirement Fund — have withdrawn their motions and no longer seek to be lead plaintiff. Dkt. Nos. 43, 61. Two other proposed lead plaintiffs — a group consisting of Citadel Financial Advisory Ltd. and Over Atlantic Investments, and Gerard Warren — have conceded that they do not have the largest financial interest in the action, though still willing to serve if requested. Dkt. Nos. 49, 44. Overall, the parties involved in the five competing motions recognize Arpat Bachhawat as "the most adequate plaintiff" under the PSLRA. They agree Bachhawat has the largest financial interest in the litigation under 15 U.S.C. § 78u-4(a)(3)(B)(iii)(I), and do not object that he meets the requirements of Federal Rule of Civil Procedure 23, including typicality and adequacy, for this litigation. Dkt. Nos. 43, 44, 49, 54. At the hearing, no objections were raised. Consequently, the Court appoints Arpan Bachhawat as lead plaintiff in the consolidated securities class action.

Bachhawat requests that the Court appoint the law firm of Faruqi & Faruqi to represent the class as lead counsel, pursuant to 15 U.S.C. § 78u-4(a)(3)(B)(v). Dkt. No. 26 at 9. All objections from other parties having been withdrawn, see Dkt. No. 54, and because no objections were raised at the hearing, the Court will allow Bachhawat's choice of counsel. Dkt. No. 26 is granted, and the other motions, Dkt. Nos. 17 and 21, are denied, without prejudice to renewal in the event that Bachhawat should ever become unwilling or unable to serve as lead plaintiff.

II. AMENDED SCHEDULING ORDER

The Court revises the schedule for this case. Dkt. No. 48. Lead plaintiff is ordered to file a consolidated amended complaint by January 29, 2016. Defendants are to respond to the consolidated amended complaint by February 19, 2016. If defendants file a motion to dismiss, plaintiff's response is due by March 11, 2016, and any reply is due by March 25, 2016. These dates are firm and will not be continued. The Court will then decide whether to set a hearing on the motion.

The consolidated amended complaint will be the operative complaint and supersede all other complaints filed in each of the underlying actions that were consolidated into this case. Defendants need not respond to those prior complaints.

Pursuant to the PSLRA and the Federal Rules of Civil Procedure, and for the sake of clarity and efficient case management, plaintiff is directed to set out in chart form its securities fraud allegations under the following headings on a numbered, statement-by-statement basis: (1) the speaker(s), date(s), and medium; (2) the false and misleading statements; (3) the reasons why the statements were false and misleading when made; and (4) the facts giving rise to a strong inference of scienter. An exemplar can be found at Docket Number 111 in In re Mellanox Technologies, Ltd. Securities Litigation, Case No. 13-cv-4909. The chart may be attached to or contained in the consolidated complaint, but in any event will be deemed to be a part of the complaint.

IT IS SO ORDERED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer